GlaxoSmithKline is expected to announce a deal to buy Human Genome Sciences for about $2.8 billion as soon as Monday, ending a three-month hostile pursuit of the U.S. biotech company on friendly terms after sweetening its offer
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment